FDA Brief

Warning letters Biologics

FDA warning letter to

MiMedx Group, Inc.

Issued Dec 20, 2023Posted Jan 9, 2024Center for Biologics Evaluation and Research (CBER)

Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps). We haven't summarized this letter yet. Read it on fda.gov.